Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypogonadotropic hypogonadism.

Leticia F G Silveira1, Gavin S MacColl, Pierre M G Bouloux

  • 1Department of Medicine, Neuroendocrine Unit, Royal Free and University College Medical School, London, United Kingdom.

Seminars in Reproductive Medicine
|January 22, 2003
PubMed
Summary

Hypogonadotropic hypogonadism, a failure of gonadal function due to deficient gonadotropin secretion, is linked to genetic mutations affecting reproductive axis development. Treatment options focus on puberty, hormone replacement, and fertility induction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A core outcome set for pituitary surgery research: an international delphi consensus study.

Pituitary·2025
Same author

Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement.

Pituitary·2025
Same author

Predictive factors for treatment response in active thyroid eye disease.

Annales d'endocrinologie·2024
Same author

Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres.

The lancet. Diabetes & endocrinology·2024
Same author

Association between KISS1 rs5780218 promoter polymorphism and onset of growth hormone secreting pituitary adenoma.

Annales d'endocrinologie·2018
Same author

Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.

The aging male : the official journal of the International Society for the Study of the Aging Male·2015

Area of Science:

  • Endocrinology
  • Reproductive Medicine
  • Genetics

Background:

  • Hypogonadotropic hypogonadism (HH) results from deficient gonadotropin secretion due to hypothalamic or pituitary defects.
  • It is often associated with structural or functional abnormalities in these regions.
  • The genetic underpinnings of idiopathic HH are increasingly understood through mutations in key developmental genes.

Purpose of the Study:

  • To review the genetic basis of hypogonadotropic hypogonadism.
  • To discuss the role of specific genes in the hypothalamo-pituitary-gonadal axis.
  • To outline current treatment strategies for HH.

Main Methods:

  • Review of genetic mutations implicated in HH pathogenesis.
  • Analysis of genes involved in reproductive axis development and function.

Related Experiment Videos

  • Summary of established treatment modalities for HH.

    • Main Results:

    • Mutations in genes like KAL-1, GnRH receptor, and transcription factors (HESX1, LHX3, PROP-1) are linked to HH.
    • Genes such as DAX-1, SF-1, leptin, leptin receptor, and PC1 are also implicated.
    • Understanding these mutations enhances knowledge of reproductive axis physiology.

    Conclusions:

    • Genetic mutations play a significant role in the pathogenesis of hypogonadotropic hypogonadism.
    • Targeted therapies can induce puberty, maintain hormone levels, and restore fertility.
    • Treatment approaches, including gonadotropin or GnRH therapy, are tailored to the specific etiology.